SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-21-000281
Filing Date
2021-05-19
Accepted
2021-05-19 08:46:09
Documents
17
Period of Report
2021-05-19
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K rare-20210519.htm   iXBRL 8-K 41297
2 EX-99.1 rare-20210519-ex99_1.htm EX-99.1 29444
3 GRAPHIC img97323024_0.jpg GRAPHIC 375412
4 GRAPHIC img97323024_3.jpg GRAPHIC 25640
5 GRAPHIC img97323024_2.jpg GRAPHIC 375412
6 GRAPHIC img97323024_1.jpg GRAPHIC 25640
  Complete submission text file 0000950170-21-000281.txt   1282451

Data Files

Seq Description Document Type Size
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT rare-20210519_lab.xml EX-101.LAB 12931
8 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT rare-20210519.xsd EX-101.SCH 2249
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT rare-20210519_pre.xml EX-101.PRE 9590
10 EXTRACTED XBRL INSTANCE DOCUMENT rare-20210519_htm.xml XML 4522
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 21938481
SIC: 2834 Pharmaceutical Preparations